Woman covered in safety medical suit holding a refrigerator box

In global clinical trials, the path to a medical breakthrough relies heavily on the accuracy of laboratory data.

Moving biological specimens, biomarkers, and patient samples from clinical sites directly to central laboratories through Direct-to-lab (DTL) logistics demands an extraordinary level of precision.​


QuickSTAT’s dedicated DTL service provides an expedited, high-priority pipeline for clinical specimens. From specialised handling protocols and temperature management to regulatory expertise, see how to keep your critical samples safe and your laboratory timelines on track.

What you'll learn

  • How QuickSTAT designs fastest-route logistics blueprints to minimise transit times for biological samples.​

  • A look at the pre-conditioned packaging solutions used to preserve sample viability, from ambient and refrigerated to deep-frozen (-20°C and -80°C).​

  • How our teams manage strict international transport regulations for biological substances (including IATA Category B infectious substances) to promote smooth customs clearance.​

  • The role of 24/7/365 command centres in tracking shipments at every checkpoint to anticipate and prevent potential transit delays.

Loading iFrame

Press play to get started.

Why it matters

  • In many clinical trials, patient biopsies or blood draws cannot be replicated. Safeguarding these specimens ensures patient efforts are never wasted.​

  • Reliable laboratory analysis depends on the sample arriving in its pristine, original state. Eliminating temperature excursions prevents sample degradation and maintains data integrity.​

  • Dependable DTL logistics means central labs receive samples sooner and experience quicker data turnarounds, patient enrollment decisions, and shorter overall trial timelines.